Sellas Life Sciences Group Inc (SLS)
Operating Cash Flow (Statement)
-$7.59M
Quarterly · Period ending: · USD
SLS Operating Cash Flow (Statement)
Latest reported-$7.59Mperiod ending
Latest reported-$7.59Mperiod ending
SLS Quarterly Cash from Operations (-$286.00K → -$7.59M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
SLS operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -7,588,000 | |
| -8,846,000 | |
| -4,921,000 | |
| -7,068,000 | |
| -7,330,000 | |
| -9,070,000 | |
| -7,153,000 | |
| -7,806,000 | |
| -9,682,000 | |
| -10,761,000 | |
| -4,825,000 | |
| -6,892,000 | |
| -7,566,000 | |
| -12,127,000 | |
| -5,152,000 | |
| -5,746,000 | |
| -5,761,000 | |
| -7,150,000 | |
| -4,976,000 | |
| -5,878,000 | |
| -4,898,000 | |
| -10,269,000 | |
| 3,424,000 | |
| -3,629,000 | |
| -3,381,000 | |
| -6,831,000 | |
| -4,176,000 | |
| -3,820,000 | |
| -4,656,000 | |
| -4,991,000 | |
| -4,555,000 | |
| -14,165,000 | |
| -6,299,000 | |
| -5,403,000 | |
| 15,249,000 | |
| -6,274,000 | |
| -9,560,000 | |
| -10,404,000 | |
| -8,000,000 | |
| -12,208,000 | |
| -11,491,000 | |
| -13,216,000 | |
| -15,284,000 | |
| -9,461,000 | |
| -11,859,000 | |
| -11,556,000 | |
| -10,743,000 | |
| -11,106,000 | |
| -12,972,000 | |
| -8,048,000 | |
| -8,471,000 | |
| -7,983,000 | |
| -7,123,000 | |
| -5,331,000 | |
| -5,168,000 | |
| -4,165,000 | |
| -6,745,000 | |
| -4,885,000 | |
| -4,169,000 | |
| -3,413,000 | |
| -4,059,000 | |
| -3,027,000 | |
| -1,869,000 | |
| -2,237,000 | |
| -3,707,000 | |
| -2,444,000 | |
| -3,288,000 | |
| -3,044,000 | |
| -2,765,000 | |
| -2,672,000 | |
| -2,735,000 | |
| -2,359,000 | |
| -2,667,000 | |
| -1,668,000 | |
| -2,192,000 | |
| -2,142,000 | |
| -649,000 | |
| -1,064,000 | |
| -286,000 |